Cytokeratin-derived markers of lung cancer. Various evaluation methods are available for aiding clinicians in lung cancer management. Some of these methods are highly specific. However, they are also invasive and burdened by non-negligible complication rates (e.g., mediastinoscopy) other methods are highly accurate and noninvasive, but require expensive equipment and well-trained personnel (e.g., PET scanning)